- Home
- XGN vs ONL Comparison
XGN vs ONL Comparison
Compare XGN & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- ONL
- Stock Information
- Founded
- XGN 2002
- ONL 2021
- Country
- XGN United States
- ONL United States
- Employees
- XGN N/A
- ONL N/A
- Industry
- XGN Medical Specialities
- ONL Real Estate Investment Trusts
- Sector
- XGN Health Care
- ONL Real Estate
- Exchange
- XGN Nasdaq
- ONL Nasdaq
- Market Cap
- XGN 138.3M
- ONL 119.7M
- IPO Year
- XGN 2019
- ONL N/A
- Fundamental
- Price
- XGN $7.27
- ONL $2.73
- Analyst Decision
- XGN Strong Buy
- ONL Hold
- Analyst Count
- XGN 3
- ONL 1
- Target Price
- XGN $9.00
- ONL N/A
- AVG Volume (30 Days)
- XGN 272.4K
- ONL 896.7K
- Earning Date
- XGN 07-29-2025
- ONL 08-06-2025
- Dividend Yield
- XGN N/A
- ONL 2.93%
- EPS Growth
- XGN N/A
- ONL N/A
- EPS
- XGN N/A
- ONL N/A
- Revenue
- XGN $56,724,000.00
- ONL $154,796,000.00
- Revenue This Year
- XGN $18.92
- ONL N/A
- Revenue Next Year
- XGN $14.78
- ONL N/A
- P/E Ratio
- XGN N/A
- ONL N/A
- Revenue Growth
- XGN 1.78
- ONL N/A
- 52 Week Low
- XGN $1.78
- ONL $1.46
- 52 Week High
- XGN $7.95
- ONL $4.39
- Technical
- Relative Strength Index (RSI)
- XGN 56.94
- ONL 70.00
- Support Level
- XGN $6.81
- ONL $2.54
- Resistance Level
- XGN $7.50
- ONL $2.77
- Average True Range (ATR)
- XGN 0.33
- ONL 0.10
- MACD
- XGN 0.02
- ONL 0.03
- Stochastic Oscillator
- XGN 75.27
- ONL 91.67
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.